MaxCyte Signs Licensing Deal With Moonlight Bio for Cell Therapy Development-September 2024-www.financetom.com

MaxCyte Signs Licensing Deal With Moonlight Bio for Cell Therapy Development

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

MaxCyte Signs Licensing Deal With Moonlight Bio for Cell Therapy Development

Oct 6, 2025 6:11 AM

08:52 AM EDT, 10/06/2025 (MT Newswires) -- MaxCyte ( MXCT ) said Monday it has entered a strategic platform license agreement with Moonlight Bio, a Seattle-based preclinical biotech firm.

The company said Moonlight Bio will use its Flow Electroporation technology and ExPERT platform to advance its T cell therapy programs.

The agreement grants Moonlight Bio non-exclusive rights for research, clinical, and commercial use, the company added.

MaxCyte ( MXCT ) said it will receive annual licensing fees and program-related revenue as part of the agreement.

Shares of MaxCyte ( MXCT ) were up 5.9% in Monday's premarket activity.

Previous page： Atlassian Insider Sold Shares Worth $2,010,941, According to a Recent SEC Filing Next page： Atlassian Insider Sold Shares Worth $394,972, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Atlassian Insider Sold Shares Worth $2,010,941, According to a Recent SEC Filing

Jan 17, 2025

05:54 PM EST, 01/17/2025 (MT Newswires) -- Scott Farquhar, 10% Owner, Director, on January 17, 2025, sold 7,948 shares in Atlassian ( TEAM ) for $2,010,941. Following the Form 4 filing with the SEC, Farquhar has control over a total of 389,452 shares of the company, with 389,452 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218025000415/xslF345X05/primarydocument.xml ...

Atlassian Insider Sold Shares Worth $394,972, According to a Recent SEC Filing

Jan 17, 2025

05:54 PM EST, 01/17/2025 (MT Newswires) -- Anutthara Bharadwaj, President, on January 17, 2025, sold 1,520 shares in Atlassian ( TEAM ) for $394,972. Following the Form 4 filing with the SEC, Bharadwaj has control over a total of 210,471 shares of the company, with 210,471 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218025000416/xslF345X05/primarydocument.xml ...

Robinhood Markets Insider Sold Shares Worth $4,113,888, According to a Recent SEC Filing

Jan 17, 2025

05:55 PM EST, 01/17/2025 (MT Newswires) -- Baiju Bhatt, Director, on January 15, 2025, sold 90,866 shares in Robinhood Markets ( HOOD ) for $4,113,888. Following the Form 4 filing with the SEC, Bhatt has control over a total of 5,042 shares of the company, with 5,042 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1783879/000178387925000026/xslF345X05/wk-form4_1737153965.xml ...

Atlassian Insider Sold Shares Worth $2,010,942, According to a Recent SEC Filing

Jan 17, 2025

05:55 PM EST, 01/17/2025 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, CEO, Co-Founder, on January 17, 2025, sold 7,948 shares in Atlassian ( TEAM ) for $2,010,942. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 389,452 shares of the company, with 389,452 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1650372/000156218025000414/xslF345X05/primarydocument.xml ...